FACULTY
Marwan Noel Sabbagh, MD, FAAN, FANA
Moreno Family Chair for Alzheimer’s Research
Vice Chairman for Research and Professor
Department of Neurology
Barrow Neurological Institute
Phoenix, AZ
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director, Family Medicine Residency Program
Abington Jefferson Health
Abington, PA
PROGRAM OVERVIEW
In this enduring grand rounds program, we will provide instruction on screening, diagnosing, and staging of mild cognitive impairment and Alzheimer’s disease. The lecture and case-based scenarios will educate on the appropriate use of disease-modifying therapy, assessing and managing adverse events associated with these therapies, and implementing tools to solve issues with access to therapy. Finally, the faculty will discuss shared decision making and multidisciplinary teams as essential elements for successful care of these patients.
TARGET AUDIENCE
This activity is designed to meet the educational needs of health care providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including primary care physicians, neurologists, geriatricians, psychiatrists, nurses, NPs, PAs, and other multidisciplinary team members.
LEARNING OBJECTIVES
- Integrate evidence-based pathways for screening, diagnosing, and staging MCI and AD
- Appraise clinical practice recommendations informing use of DMTs for AD and identifying those who qualify for treatment based on available clinical data
- Assess and manage potential adverse events associated with DMTs for AD using a multidisciplinary approach
- Develop practice protocols to improve access to DMTs for AD
- Apply best practices for shared decision making when discussing DMT treatment for AD, including discussions of treatment benefits, risks, and what to expect with therapy
JOINT ACCREDITATION STATEMENT

PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 knowledge-based CPE contact hours.
ASWB Credit Designation Statement for Jointly Accredited Organizations (Social Worker Credit)

Social workers completing this course receive 1.0 asynchronous continuing education credit.
AAPA Credit Designation Statement — Enduring Materials

Interprofessional Continuing Education (IPCE) Credit Designation Statement

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Speaker | Relationships | Manufacturer |
Marwan Noel Sabbagh, MD | Consultant | Lilly, Anavex Life Sciences, Eisai, Signant Health, GlaxoSmithKline, Sanofi, NetraMark, Alzheon, Athira Pharma, NeuroTherapia |
Board of Directors | CervoMed | |
Neil Skolnik, MD | Consultant | AstraZeneca, Teva, Lilly, Sanofi, Sanofi Pasteur, GlaxoSmithKline, Bayer, Abbott, Novo Nordisk |
Speakers Bureau | AstraZeneca, Lilly, GlaxoSmithKline, Teva, Bayer, Heartland | |
Contracted research | AstraZeneca, GlaxoSmithKline, Novo Nordisk, Novartis |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer-reviewed by a physician and nurse reviewer.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Dominique Barton, B.S. BSN, Nursing Reviewer, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Chris Drury, Medical Director for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Associate Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: May 15, 2025
EXPIRATION DATE: May 15, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.